Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-09

Clinical Trial Update: Efficacy and Safety of Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke Risk [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy and safety of aspirin plus clopidogrel in atrial fibrillation patients at low to moderate stroke risk; current stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)
  • CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Chuncheon Sacred Heart Hospital | Conditions: Atrial Fibrillation | Phase 3 | Status: UNKNOWN